No abstract available
Keywords:
Editorials; allopurinol; cardiovascular outcomes; clinical trial; febuxostat; gout.
MeSH terms
-
Aged
-
Allopurinol
-
Cardiovascular Diseases*
-
Febuxostat
-
Gout Suppressants
-
Gout*
-
Humans
-
Risk Factors
-
Xanthine Oxidase
Substances
-
Gout Suppressants
-
Febuxostat
-
Allopurinol
-
Xanthine Oxidase